| Шығарылым |
Бөлім |
Атауы |
Файл |
| Том 27, № 8 (2020) |
Articles |
Clinical and microbiological features of atopic dermatitis in HIV-positive patients (literature review) |
|
| Том 27, № 8 (2020) |
Articles |
Clinical case of mycosis fungoides |
|
| Том 27, № 14 (2020) |
Articles |
Treatment of psoriatic erythroderma with biological drugs |
|
| Том 27, № 14 (2020) |
Articles |
Influence of inflammatory dermatoses on the quality of life of HIV-positive patients |
|
| Том 28, № 8 (2021) |
Articles |
Modern therapy of psoriasis from the point of view of systemic inflammation: experience of using the drug Efleira |
|
| Том 28, № 8 (2021) |
Articles |
Experience with dupilumab in patients with atopic dermatitis |
|
| Том 28, № 8 (2021) |
Articles |
Type 1 neurofibromatosis in Western Siberia, prevalence, features of clinical manifestations |
|
| Том 28, № 8 (2021) |
Articles |
Urine chromatography in skin diseases |
|
| Том 28, № 10 (2021) |
Articles |
Possibilities of using anti-cytokine drugs for inflammatory dermatoses in HIV-positive patients |
|
| Том 29, № 8 (2022) |
Articles |
Experience with the use of netakimab for the treatment of psoriasis in HIV-infected patients |
|
| Том 29, № 8 (2022) |
Articles |
Tuberous sclerosis: features of the clinical course and prevalence in Western Siberia |
|
| Том 29, № 8 (2022) |
Articles |
Clinical case: chronic skin fold candidiasis against the background of treatment with an interleukin-17A inhibitor in a patient with extensive severe psoriasis |
|
| Том 29, № 10 (2022) |
Articles |
Experience with the use of baricitinib in the treatment of atopic dermatitis in HIV-infected patients |
|
| Том 29, № 10 (2022) |
Articles |
The role of systemic inflammation in HIV-infected patients with moderate and severe psoriasis |
|
| Том 29, № 13 (2022) |
Articles |
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout |
|
